Pancreatic ablation: minimally invasive treatment options

References

• Varadhachary GR, Tamm EP, Abbruzzese JL, et al. Borderline resectable pancreatic cancer: definitions, management, and role of preoperative therapy. Ann Surg Oncol. 2006;13:1035–1046.
   PubMed Web of Science ®Google Scholar
• Sheahan AV, Biankin AV, Parish CR, et al. Targeted therapies in the management of locally advanced and metastatic pancreatic cancer: a systematic review. Oncotarget. 2018;21613:21627.
   Google Scholar
• Hammel P, Huguet F, Van Laethem JL, et al. Effect of chemoradiotherapy vs chemotherapy on survival in patients with locally advanced pancreatic cancer controlled after 4 months of gemcitabine with or without erlotinib the LAP07 randomized clinical trial. JAMA. 2016;315:1844–1853.
   PubMed Web of Science ®Google Scholar
• Saccomandi P, Lapergola A, Longo F, et al. Thermal ablation of pancreatic cancer: a systematic literature review of clinical practice and pre-clinical studies. Int J Hyperthermia. 2018;35:398–418.
   PubMed Web of Science ®Google Scholar
• Dai Y, Covarrubias D, Uppot R, et al. Image-guided percutaneous radiofrequency ablation of central renal cell carcinoma: assessment of clinical efficacy and safety in 31 tumors. J Vasc Interv Radiol. 2017. 28:1643–1650.
   PubMed Web of Science ®Google Scholar
• Mauri G, Gennaro N, De Beni S, et al. Real-time US-18FDG-PET/CT image fusion for guidance of thermal ablation of 18FDG-PET-positive liver metastases: the added value of contrast enhancement. Cardiovasc Intervent Radiol. 2019;42:60–68.
   PubMed Web of Science ®Google Scholar
• Zampino MG, Magni E, Ravenda PS, et al. Treatments for colorectal liver metastases: a new focus on a familiar concept. Crit Rev Oncol Hematol. 2016;108:154–163.
   PubMed Web of Science ®Google Scholar
• Shyn PB, Mauri G, Alencar RO, et al. Percutaneous imaging-guided cryoablation of liver tumors: predicting local progression on 24-hour MRI. Am J Roentgenol. 2014;203:W181–W191.
   PubMed Web of Science ®Google Scholar
• Mauri G, Nicosia L, Varano GM, et al. Tips and tricks for a safe and effective image-guided percutaneous renal tumour ablation. Insights Imaging. 2017;8:357–363.
   PubMed Web of Science ®Google Scholar
• Mauri G, Sconfienza LM, Pescatori LC, et al. Technical success, technique efficacy and complications of minimally-invasive imaging-guided percutaneous ablation procedures of breast cancer: a systematic review and meta-analysis. Eur Radiol. 2017;27:3199.
   PubMed Web of Science ®Google Scholar
• Mauri G, Beni S, De Forzoni L, et al. Virtual navigator automatic registration technology in abdominal application. Annual International Conference of the IEEE Engineering in Medicine and Biology Society; 2014 Aug 26–30; Chicago, Illinois: IEEE; 2014.
   Google Scholar
• Mauri G. Expanding role of virtual navigation and fusion imaging in percutaneous biopsies and ablation. Abdom Imaging. 2015;40:3238–3239.
   PubMedGoogle Scholar
• Mauri G, Cova L, De Beni S, et al. Real-time US-CT/MRI image fusion for guidance of thermal ablation of liver tumors undetectable with US: results in 295 cases. Cardiovasc Intervent Radiol. 2015;38:143–151.
   PubMed Web of Science ®Google Scholar
• Mauri G, Nicosia L, Verano GM, et al. Unusual tumour ablations: report of difficult and interesting cases. Ecancermedicalscience. 2017;11:733.
   PubMed Web of Science ®Google Scholar
• Mauri G, Porazzi E, Cova L, et al. Intraprocedural contrast-enhanced ultrasound (CEUS) in liver percutaneous radiofrequency ablation: clinical impact and health technology assessment. Insights Imaging. 2014;5:209–216.
   PubMedGoogle Scholar
• Solbiati L, Ahmed M, Cova L, et al. Small liver colorectal metastases treated with percutaneous radiofrequency ablation: local response rate and long-term survival with up to 10-year follow-up. Radiology. 2012;265:958–968.
   PubMed Web of Science ®Google Scholar
• Papini E, Pacella CM, Solbiati LA, et al. Minimally-invasive treatments for benign thyroid nodules: a Delphi-based consensus statement from the Italian minimally-invasive treatments of the thyroid (MITT) group. Int J Hyperth. 2019;36:376–382.
   PubMed Web of Science ®Google Scholar
• Girelli R, Frigerio I, Giardino A, et al. Results of 100 pancreatic radiofrequency ablations in the context of a multimodal strategy for stage III ductal adenocarcinoma. Langenbeck’s Arch Surg. 2013;398:63–69.
   PubMed Web of Science ®Google Scholar
• D’Onofrio M, Barbi E, Girelli R, et al. Radiofrequency ablation of locally advanced pancreatic adenocarcinoma: an overview. World J Gastroenterol. 2010;16:3478–3483.
   PubMed Web of Science ®Google Scholar
• D’Onofrio M, Ciaravino V, De Robertis R, et al. Percutaneous ablation of pancreatic cancer. World J Gastroenterol. 2016;22:9661.
   PubMed Web of Science ®Google Scholar
• D’Onofrio M, Crosara S, De Robertis R, et al. Percutaneous radiofrequency ablation of unresectable locally advanced pancreatic cancer: preliminary results. Technol Cancer Res Treat. 2017;16:285–294.
   PubMed Web of Science ®Google Scholar
• Rossi S, Viera FT, Ghittoni G, et al. Radiofrequency ablation of pancreatic neuroendocrine tumors: a pilot study of feasibility, efficacy, and safety. Pancreas. 2014;43:938.
   PubMed Web of Science ®Google Scholar
• Giardino A, Girelli R, Frigerio I, et al. Triple approach strategy for patients with locally advanced pancreatic carcinoma. HPB. 2013;15:623–627.
   PubMed Web of Science ®Google Scholar
• Wu Y, Tang Z, Fang H, et al. High operative risk of cool-tip radiofrequency ablation for unresectable pancreatic head cancer 1. J Surg Oncol. 2006;94:392–395.
   PubMed Web of Science ®Google Scholar
• Spiliotis JD, Datsis AC, Michalopoulos NV, et al. Radiofrequency ablation combined with palliative surgery may prolong survival of patients with advanced cancer of the pancreas. Langenbeck’s Arch Surg. 2007;392:55–60.
   PubMed Web of Science ®Google Scholar
• D’Amico F, Finotti M, Di Renzo C, et al. Microwave thermal ablation in an unusual case of malignant and locally advanced rare tumor of pancreas in ASA IV old male patient and literature review. Case Rep Gastrointest Med. 2018;2018:1–7.
   Google Scholar
• Lygidakis NJ, Sharma SK, Papastratis P, et al. Microwave ablation in locally advanced pancreatic carcinoma – a new look. Hepatogastroenterology. 2007;54:1305–1310.
   PubMed Web of Science ®Google Scholar
• Vogl TJ, Panahi B, Albrecht MH, et al. Microwave ablation of pancreatic tumors. Minim Invasive Ther Allied Technol. 2018;27:33–40.
   PubMed Web of Science ®Google Scholar
• Carrafiello G, Ierardi AM, Fontana F, et al. Microwave ablation of pancreatic head cancer: safety and efficacy. J Vasc Interv Radiol. 2013;24:1513–1520.
   PubMed Web of Science ®Google Scholar
• Ierardi AM, Biondetti P, Coppola A, et al. Percutaneous microwave thermosphere ablation of pancreatic tumours. Gland Surg. 2018;7:59.
   PubMed Web of Science ®Google Scholar
• Welch AJ, Van Gemert MJC. Optical-thermal response of laser-irradiated tissue. Berlin: Springer; 2011.
   Google Scholar
• Mainini AP, Monaco C, Pescatori LC, et al. Image-guided thermal ablation of benign thyroid nodules. J Ultrasound. 2017;20:11–22.
   PubMed Web of Science ®Google Scholar
• Mauri G, Cova L, Ierace T, et al. Treatment of metastatic lymph nodes in the neck from papillary thyroid carcinoma with percutaneous laser ablation. Cardiovasc Intervent Radiol. 2016;39:1023–1030.
   PubMed Web of Science ®Google Scholar
• Mauri G, Nicosia L, Della Vigna P, et al. Percutaneous laser ablation for benign and malignant thyroid diseases. Ultrasonography. 2019;38:25–36.
   PubMed Web of Science ®Google Scholar
• Patelli G, Ranieri A, Paganelli A, et al. Transperineal laser ablation for percutaneous treatment of benign prostatic hyperplasia: a feasibility study. Cardiovasc Intervent Radiol. 2017;40:1440.
   PubMed Web of Science ®Google Scholar
• Sartori S, Mauri G, Tombesi P, et al. Ultrasound-guided percutaneous laser ablation is safe and effective in the treatment of small renal tumors in patients at increased bleeding risk. Int J Hyperth. 2018;1:7.
   Google Scholar
• Di Matteo FM, Saccomandi P, Martino M, et al. Feasibility of EUS-guided Nd:YAG laser ablation of unresectable pancreatic adenocarcinoma. Gastrointest Endosc. 2018;88:168–174.e1.
   PubMed Web of Science ®Google Scholar
• Yoon WJ, Seo DW. Endoscopic ultrasound-guided local therapy of pancreatic tumors. Korean J Gastroenterol. 2015;66:154.
   PubMedGoogle Scholar
• Cazzato RL, Garnon J, Ramamurthy N, et al. Percutaneous image-guided cryoablation: current applications and results in the oncologic field. Med Oncol. 2016;33:1–16.
   PubMed Web of Science ®Google Scholar
• Xu K-C, Niu L-Z, Hu Y-Z, et al. A pilot study on combination of cryosurgery and 125iodine seed implantation for treatment of locally advanced pancreatic cancer. World J Gastroenterol. 2008;14:1603–1611.
   PubMed Web of Science ®Google Scholar
• Niu LZ, Li HB, Wen WF, et al. Feasibility and safety of percutaneous cryoablation for locally advanced pancreatic cancer. Zhonghua Yixianbing Zazhi. 2011;11:1–4.
   Google Scholar
• Niu L, Chen J, He L, et al. Combination treatment with comprehensive cryoablation and immunotherapy in metastatic pancreatic cancer. Pancreas. 2013;42:1143.
   PubMed Web of Science ®Google Scholar
• Paiella S, Salvia R, Girelli R, et al. Role of local ablative techniques (radiofrequency ablation and irreversible electroporation) in the treatment of pancreatic cancer. Updates Surg. 2016;68:307.
   PubMed Web of Science ®Google Scholar
• Venkat S, Hosein PJ, Narayanan G. Percutaneous approach to irreversible electroporation of the pancreas: Miami Protocol. Tech Vasc Interv Radiol. 2015;18:153–158.
   PubMed Web of Science ®Google Scholar
• Tasu JP, Vesselle G, Herpe G, et al. Irreversible electroporation for locally advanced pancreatic cancer: where do we stand in 2017? Pancreas. 2017;46:283.
   PubMed Web of Science ®Google Scholar
• Leen E, Picard J, Stebbing J, et al. Percutaneous irreversible electroporation with systemic treatment for locally advanced pancreatic adenocarcinoma. J Gastrointest Oncol. 2018;9:275–281.
   PubMed Web of Science ®Google Scholar
• Narayanan G, Hosein PJ, Beulaygue IC, et al. Percutaneous image-guided irreversible electroporation for the treatment of unresectable, locally advanced pancreatic adenocarcinoma. J Vasc Interv Radiol. 2017;28:342–348.
   PubMed Web of Science ®Google Scholar
• Månsson C, Bergenfeldt M, Brahmstaedt R, et al. Safety and preliminary efficacy of ultrasound-guided percutaneous irreversible electroporation for treatment of localized pancreatic cancer. Anticancer Res. 2014;34:289–293.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Shi J, Zeng J, et al. Percutaneous irreversible electroporation for ablation of locally advanced pancreatic cancer experience from a Chinese institution. Pancreas. 2017;46:e12.
   PubMedGoogle Scholar
• Månsson C, Brahmstaedt R, Nilsson A, et al. Percutaneous irreversible electroporation for treatment of locally advanced pancreatic cancer following chemotherapy or radiochemotherapy. Eur J Surg Oncol. 2016;42:1401–1406.
   PubMed Web of Science ®Google Scholar
• Luo J, Ren X, Yu T. Efficacy of extracorporeal ultrasound-guided high intensity focused ultrasound: an evaluation based on controlled trials in China. Int J Radiat Biol. 2015;91:480–485.
   PubMed Web of Science ®Google Scholar
• Orsi F, Mauri G. HIFU and radio frequency as alternatives to surgery In: Veronesi U, Goldhrisch A, editors. Breast cancer: innovations in research and management. Switzerland: Springer International Publishing; 2017. p. 849–854.
   Google Scholar
• Mauri G, Nicosia L, Xu Z, et al. Focused ultrasound: tumour ablation and its potential to enhance immunological therapy to cancer. BJR. 2018;91:20170641.
   Google Scholar
• Zhou Y-F. High intensity focused ultrasound in clinical tumor ablation. World J Clin Oncol. 2010;2:8–27.
   Google Scholar
• Orgera G, Monfardini L, Della Vigna P, et al. High-intensity focused ultrasound (HIFU) in patients with solid malignancies: evaluation of feasibility, local tumour response and clinical results. Radiol Med. 2011;116:734–748.
   PubMed Web of Science ®Google Scholar
• Orsi F, Orgera G. Does it have a role in breast cancer? Cardiovasc Intervent Radiol. 2010. https://doi.org/10.1007/s00270-010-9954-3
   Google Scholar
• Wang K, Chen Z, Meng Z, et al. Analgesic effect of high intensity focused ultrasound therapy for unresectable pancreatic cancer. Int J Hyperth. 2011;27:101–107.
   PubMed Web of Science ®Google Scholar
• Gao HF, Wang K, Meng ZQ, et al. High intensity focused ultrasound treatment for patients with local advanced pancreatic cancer. Hepatogastroenterology. 2013;60. https://doi.org/10.5754/hge13498
   Google Scholar
• Melodelima D, Chapelon JY, Theillère Y, et al. Combination of thermal and cavitation effects to generate deep lesions with an endocavitary applicator using a plane transducer: ex vivo studies. Ultrasound Med Biol. 2004;30:103–111.
   PubMed Web of Science ®Google Scholar
• Dababou S, Marrocchio C, Scipione R, et al. High-intensity focused ultrasound for pain management in patients with cancer. RadioGraphics. 2018;38:603.
   PubMed Web of Science ®Google Scholar
• Vidal-Jove J, Perich E, Del Castillo MA. Ultrasound guided high intensity focused ultrasound for malignant tumors: the Spanish experience of survival advantage in stage III and IV pancreatic cancer. Ultrason Sonochem. 2015;27:703–706.
   PubMed Web of Science ®Google Scholar
• Marinova M, Rauch MM, Mücke M, et al. High-intensity focused ultrasound (HIFU) for pancreatic carcinoma: evaluation of feasibility, reduction of tumour volume and pain intensity. Eur Radiol. 2016;26:4047–4056.
   PubMed Web of Science ®Google Scholar
• Wu F. High intensity focused ultrasound: a noninvasive therapy for locally advanced pancreatic cancer. World J. Gastroenterol. 2014;20:16480–16488.
   PubMed Web of Science ®Google Scholar